Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker

Head and neck squamous cell carcinoma (HNSCC) is a type of tumour with a relatively poor prognosis. In recent years, immune checkpoint inhibitors, such as CTLA-4 and PD-1/PDL-1 inhibitors, have improved the treatment status of advanced tumours. However, the emergence of drug resistance has brought d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaoting, Kadasah, Sultan, Xie, Jiaheng, Gu, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061055/
https://www.ncbi.nlm.nih.gov/pubmed/35510041
http://dx.doi.org/10.1155/2022/3051907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061055/
https://www.ncbi.nlm.nih.gov/pubmed/35510041
http://dx.doi.org/10.1155/2022/3051907

Ejemplares similares